当前位置：   首页 > 需求大厅

防粘连产品属于三类医疗器械，现需要其终端医院销售数据、市场分析等方面信息。具体价格再议。   [更多]

求购Mosapride Citrate Tablets《JP17(英)》的药典标准一份   [更多]

我公司现寻求吸入制剂研发平台合作，可投资入股、可引进并购，为我公司吸入制剂研究提供技术和平台支撑。 要求：具备基本的吸入制剂研发仪器设备和人员；研发体系搭建完善；有一定的项目基础。   [更多]

印度原料药技术转让，多个品种 序号 产品目录 产品类别 STATUS／文件状态 1 盐酸阿地芬宁 局部麻醉剂 TECH PACK 2 巴多昔芬 骨质疏松症的预防与抗肿瘤 TECH PACK 3 卡维地洛磷酸盐 抗高血压 TECH PACK 4 西替利司他 抗肥胖药物 TECH PACK 5 "羟乙桂胺" 骨骼肌松弛剂 TECH PACK 6 铁山梨醇糊精柠檬酸络合物 补血药物 TECH PACK   [更多]

求购“Solifenacin+succinate”《 EP9.0 》的药典标准一份   [更多]

1、产能充足，承接委托生产：江西省内（中药、化药常规制剂），浙江省（软胶囊剂），江苏省（三滴制剂） 2、代理销售：创新销售模式，依托平台资源，代理销售开拓市场（OTC、处方药、保健品） 3、投资并购：收购产品，投资合作。   [更多]

由中国人体健康科技促进会医药科技专业委员会、世界中医药学会联合会国际合作部、《世界中医药》杂志社联合主办、药智网承办的“第二届国际中医药临床研究新进展暨养生保健学术大会”将于2015年8月16至19日在中国贵州省贵阳市华美达神奇大酒店举行。 【会议目的】 增进中医中药学术的交流与合作，提高学术水平，加快中医现代化、国际化、标准化的进程，提高人民身心健康 【会议内容】 （一）中医临床及养生保健 （二）中药的临床应用及研发与创新 【参会对象】 全国知名中药生产企业 中医药方面的学术大师 海峡两岸及香港、澳门相关单位领导 国医大师 院士 专业领域著名专家 学者 【咨询方式】 联系人：李红艳 18290573438 qq：1913555909 世界中医药杂志： 《世界中医药》杂志创刊于2006年，主要栏目有专题、论坛、理论研究、临床研究、老中医经验、临证体会、针灸经络、思路与方法、实验研究、中药研究、海外中医药、学科研究、综述、名企名药等。 名额有限 火热报名中！   [更多]

理论分析一种材料，能有明显区分其与丙酮或水（潮湿）的物理作用。如膨胀，收缩，卷曲，等等。此材料不限于纤维，膜剂或织物。 “请于2016年5月23日之前将稿件上传到：https://www.innocentive.com/ar/challenge/9933858 “ Challenge Overview Many materials (usually polymers) change shape when exposed to acetone (ketones in general) but also have a large affinity for moisture as well. It would be very difficult to attribute physical changes to acetone or water if both were present. The Seeker is looking for materials and associated processes that produce an observable physical change to the substrate upon exposure to acetone. The material should not have the same effect when exposed to moisture so the two can be differentiated. The effect should be reversible and the rate of absorb/desorb should be similar. This is a Theoretical Challenge that requires only a written proposal to be submitted. The Challenge award will be contingent upon theoretical evaluation of the proposal by the Seeker. To receive an award, the Solvers will have to transfer to the Seeker their exclusive Intellectual Property (IP) rightsto the solution. However, the Seeker will be willing to consider a licensing agreement for a partial award if exclusive IP cannot be transferred by the Solver. Submissions to this Challenge must be received by 11:59 PM (US Eastern Time) on May 23, 2016. Late submissions will not be considered.   [更多]

再生药的发展领域，主要集中在修复和取代受损细胞组织或病源组织。干细胞有自我修复功能。胚胎干细胞可以开发成身体内任何形式的细胞组织，成体干细胞的功能是维护或修复身体内部的细胞。Boiheringer Ingelheim的寻找目标是：调动，刺激，分化新的内源性干细胞分子结构的途径。 投标截止时期2016年6月24日, 投标网址：https://www.innocentive.com/ar/challenge/9933855 原文 Mobilization, Stimulation, and Differentiation of Endogenous Stem Cells TAGS: Chemistry, Royal Society of Chemistry, Life Sciences, Ideation AWARD: $15,000 USD | DEADLINE: 6/24/16 | ACTIVE SOLVERS: 51 | POSTED: 4/25/16 1. The Challenge and qualification for the award During early development, embryonic stem cells are undifferentiated cells that can be stimulated to proliferate and develop into all different cell types. In adults, these endogenous cells are found in tissues and they can divide either to replenish the stem cell population or differentiate into specialized cells of the tissue in which they reside. These adult stem cells function as an internal maintenance or repair system, so it would be beneficial to be able to direct and enhance this regenerative capacity. Therefore, Boehringer Ingelheim (the Seeker) desires the identification of new molecular mechanisms and pathways involved in mobilization, stimulation, and differentiation of endogenous stem cells. All submitted solutions will be considered for the award. There will be a guaranteed award for at least one submitted solution. The total payout will be $15,000, with the possibility to distribute it amongst one or more Solvers, with at least one award being no smaller than $5,000 and no award being smaller than $1,000. 2. Additional application for Research Funding In addition to consideration for the award for the submitted solutions, Solvers with appropriate qualifications and expertise having access to a suitable research laboratory and equipment can apply for research funding (“Research Funding”) to execute the research plan that is proposed in the solution. The selection of candidates for Research Funding will be conducted after completion of this Challenge   [更多]

为健康动物做明显标记的染料或颜料，通常有以下2种限制： 1. 染料往往是活性的，因此不容易褪色，并有强烈的产品活性成分。 2. 颜料活性低，不粘附皮肤，所以容易被清洗。 目标要求是研发一种能在动物体上染色的环保材料（如：染料，颜料或其他） 或者一种配方能够达到相同效果。 投标截止时期2016年5月29日, 投标网址https://www.innocentive.com/ar/challenge/9933850 原文 Challenge Overview The Seeker to this Challenge has a cleaning product for animal hygiene to which the Seeker intends to add the capability to stain skin with a clear, visible mark. Various dyes and pigments exist with the potential to provide this feature, however two limitations have been found: • Dyes tend to be reactive, hence not staining and consuming the active ingredient of the product. • Pigments are less reactive, do not adhere to skin, and are therefore easily washed out. The Challenge is to develop a highly colored version of the cleaning product adding to it the ability to stain animal skin. Hence, the Seeker is looking for ideas for ingredients (dyes, pigments, or others) and/or formulations that can overcome the above identified limitations and achieve this effect. This is a Theoretical Challenge that requires only a written proposal to be submitted. The Challenge award will be contingent upon theoretical evaluation of the proposal by the Seeker. Submissions to this Challenge must be received by 11:59 PM (US Eastern Time) on May 29, 2016. Late submissions may not be considered. To receive an award, the Solvers will have to transfer to the Seeker their exclusive Intellectual Property (IP) rightsto the solution.   [更多]